“…This led researchers to a design of synthetic tailor-made cationic 7-positively charged blockers based on a sevenfold symmetrical β-cyclodextrin (7+βCD) core (reviewed in [103]) (Table 38.2). The designed compounds have shown in vitro, in cell cultures, and in vivo (in the case of anthrax toxin) activity against four different binary bacterial toxins (i.e., anthrax, C2, iota, and CDT), thus representing the potential for the development of universal blockers against these toxins [77,84,89,[104][105][106][107]. The cyclodextrins, which are cyclic oligomers of glucose, have a long and successful history of being employed in the pharmaceutical, agrochemical, environmental, cosmetic, and food industries [108] because of their ability to form water-soluble inclusion complexes with different small molecules and portions of large molecules.…”